Budesonide Inhaler Market

Budesonide Inhaler Market
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Budesonide Inhaler Market – Overview
Budesonide is a medication that is used to prevent symptoms of asthma. It is a corticosteroid or steroid
(cortisone-like medicine). The medication prevents inflammation in the lungs to decrease the severity of
asthma attack. Inhaled budesonide may be used with other asthma medicines such as bronchodilators,
which are also used to open up narrowed breathing passages in the lungs. Budesonide is available in
several forms such as powders, suspensions, and tablets. In powder form, the medication can be inhaled by
mouth using an inhaler. It can also be used as suspension to inhale by mouth using a special jet nebulizer
(machine that turns medication into a mist that can be inhaled). Some of the trade names under which
budesonide is sold are Pulmicort, Rhinocort, and Entocort.
The global budesonide inhaler market size was valued at US$ 5.25 billion in 2017, and is expected to
witness a CAGR of 5.8% over the forecast period (2018 – 2026).
REPORT DESCRIPTION
Budesonide Inhaler Market – Taxonomy
The global demand for budesonide inhaler is expected to witness substantial growth over the forecast
period, owing to increasing incidences and prevalence of asthma. According to the Global Asthma Report
2018, asthma causes around 1000 deaths every day and affects as many as 339 million people worldwide.
However, product recalls due to failure to meet regulatory guidelines is expected to hinder the market
growth. For instance, in 2014, AstraZeneca’s PULMICORT RESPULES (budesonide inhalation
suspension) was recalled by the U.S. FDA as budesonide may be above or below the specification range,
which can be harmful for the patients.
Download PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/2551
REPORT DESCRIPTION
Budesonide Inhaler Market – Key Players
•
•
•
•
•
•
•
•
•
•
Pfizer Inc.
Cipla Limited
Lupin Limited
Cosmo Pharmaceuticals
Takeda Pharmaceutical Company Ltd.
Manus Aktteva Biopharma LLP
Abbott Laboratories
Lunan Better Pharmaceutical
Novartis International AG (Sandoz)
Mylan N.V
Read More @
https://www.coherentmarketinsights.com/market-insight/budesonide-inhaler-market-2551
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an ofce at the global fnancial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We ofer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
MEDICAL DEVICES




CLINICAL
DIAGNOSTIC
MEDICAL IMAGING
Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
 Private and Government organization
 Outsourcing Companies
 Universities and Business Schools.
HEALTHCARE IT
PHARMACEUTICAL
ABOUT US
KEY STATS
100
+
150+
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
Insights Published Per Year
Consulting Projects Till
Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at ofering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702

Budesonide is a medication that is used to prevent symptoms of asthma. It is a corticosteroid or steroid (cortisone-like medicine). The medication prevents inflammation in the lungs to decrease the severity of asthma attack.

Download Report